These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2918051)

  • 1. Chronic treatment with pirenzepine decreases growth hormone secretion in insulin-dependent diabetes mellitus.
    Martina V; Maccario M; Tagliabue M; Corno M; Camanni F
    J Clin Endocrinol Metab; 1989 Feb; 68(2):392-6. PubMed ID: 2918051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects.
    Arends J; Wagner ML; Willms BL
    J Clin Endocrinol Metab; 1988 Feb; 66(2):389-94. PubMed ID: 3339112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Martina V; Pontiroli AE; Tagliabue M; Calderara A; Maccario M; Pacchioni M; Bertaina S; Bruno G; Pozza G; Camanni F
    Horm Metab Res; 1994 Mar; 26(3):148-51. PubMed ID: 8005563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early morning hyperglycemia in insulin-dependent diabetes: acute and sustained effects of cholinergic blockade.
    Atiea JA; Creagh F; Page M; Owens DR; Scanlon MF; Peters JR
    J Clin Endocrinol Metab; 1989 Aug; 69(2):390-5. PubMed ID: 2666430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
    Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic muscarinic receptor blockade with pirenzepine abolishes slow wave sleep-related growth hormone release in young patients with insulin-dependent diabetes mellitus.
    Page MD; Koppeschaar HP; Dieguez C; Gibbs JT; Hall R; Peters JR; Scanlon MF
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):355-9. PubMed ID: 3652479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus.
    Krassowski J; Szulc P; Makowska A; Godziejewska M; Jeske W; Zgliczynski S
    Diabetes Res Clin Pract; 1993 Mar; 19(3):211-6. PubMed ID: 8319519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pirenzepine on growth hormone and blood glucose levels in type I diabetes mellitus. A controlled study in patients on basal bolus insulin treatment.
    Pietschmann P; Schernthaner G
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):315-9. PubMed ID: 3289300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of growth hormone (GH) response to GHRH in diabetes mellitus type 1 after blockade of the cholinergic system with pirenzepine].
    Krassowski J; Rogala H; Jeske W; Zgliczyński S
    Pol Arch Med Wewn; 1992 Jul; 88(1):25-9. PubMed ID: 1454656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone (GH) secretion in type I diabetes mellitus: further evidence supporting somatostatin's involvement in GH suppression.
    Goñi MJ; Monreal M; Goñi F; Sopena M; Gil MJ; Moncada E; Salvador J
    Metabolism; 1997 Nov; 46(11):1305-11. PubMed ID: 9361690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of glucose and growth hormone responses to meals and exercise in type 1 diabetes by cholinergic muscarinic blockade.
    Ara J; Kang S; Creagh FM; Scanlon MF; Peters JR
    Diabet Med; 1994; 11(1):92-7. PubMed ID: 8181260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes.
    Aman J; Kroon M; Karlsson I; Jones I; Hagenäs L
    Acta Paediatr; 1996 Jan; 85(1):31-7. PubMed ID: 8834976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic treatment improves glycaemic control in adolescent girls with insulin-dependent diabetes mellitus.
    Halldin MU; Aman J; Brismar K; Jones I; Tuvemo T; Gustafsson J
    Acta Paediatr; 2001 Apr; 90(4):393-9. PubMed ID: 11332929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes.
    Martina V; Tagliabue M; Maccario M; Bertagna A; Ghigo E; Massara F; Camanni F
    Horm Metab Res; 1987 Sep; 19(9):449-50. PubMed ID: 3692441
    [No Abstract]   [Full Text] [Related]  

  • 15. The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.
    Chiodera P; Coiro V; Speroni G; Capretti L; Muzzetto P; Volpi R; Butturini U
    J Clin Endocrinol Metab; 1984 Oct; 59(4):794-7. PubMed ID: 6434581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
    Pal BR; Matthews DR; Edge JA; Mullis PE; Hindmarsh PC; Dunger DB
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):93-100. PubMed ID: 8435890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.
    Halldin MU; Brismar K; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):735-43. PubMed ID: 12460323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
    Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics.
    Bevan JS; Ara J; Page MD; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):85-91. PubMed ID: 1889143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous inhibition by pirenzepine of the GH responses to GnRH and TRH in insulin-dependent diabetics and in patients with major depression.
    Coiro V; Volpi R; Capretti L; Speroni G; Castelli A; Mosti A; Marchesi C; Gardini E; Rossi G; Chiodera P
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):143-8. PubMed ID: 2492706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.